Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
A mid-sized API manufacturer is moving into semiconductor and battery chemicals, segments critical to India’s localization ...
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
Flexxbotics, the autonomous manufacturing platform leader, announced the release of its software-defined automation as a free ...
Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, ...
SSH Manufacturing rose from a humble neighborhood shop into a high-performance global supplier trusted by international ...
Learn how oil and gas manufacturers can boost efficiency by 25% while maintaining product integrity through Six Sigma, TPM ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback